bioMérieux S.A.

Paris Stock Exchange:BIM.PA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

France

Market Cap

USD 16.21 B

Share Price

USD 136.66

Avg Daily Volume

126,647

Change (1 day)

0.21%

Change (1 year)

41.52%

Change (YTD)

27.51%

bioMérieux S.A. Price to Book Ratio (P/B) on June 19, 2025: 3.72

bioMérieux S.A. Price to Book Ratio (P/B) is 3.72 on June 19, 2025, a 35.14% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

bioMérieux S.A. 52-week low Price to Book Ratio (P/B) is 3.86 on June 19, 2025, which is 3.81% above the current Price to Book Ratio (P/B).
bioMérieux S.A. 52-week low Price to Book Ratio (P/B) is 2.71 on June 19, 2025, which is -27.21% below the current Price to Book Ratio (P/B).
bioMérieux S.A. average Price to Book Ratio (P/B) for the last 52 weeks is 3.28.

Daily

From:

To:

Zoom:

Key data

Date	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield

Paris Stock Exchange: BIM.PA

bioMérieux S.A.

CEO	Mr. Pierre Boulud
IPO Date	July 7, 2004
Location	France
Headquarters	376 Chemin De l'Orme
Employees	14,147
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.